European Clinical Supply Planning – Balancing Cost, Flexibility And Time

The packaging and distribution of clinical supplies play a critical role in the overall success of a clinical trial, and proactive planning can significantly improve supply chain efficiency. Establishing a well-designed supply strategy early in the development process helps ensure that investigational products reach clinical sites on time, support protocol compliance, and minimize the risk of delays that could impact patient enrollment or study timelines. However, determining the most appropriate geographical location for packaging and distribution activities is not always straightforward. The optimal approach often depends on several factors, including the specific requirements of the clinical trial protocol, broader business and operational considerations, and the characteristics of the investigational medicinal product (IMP) itself, such as stability, handling requirements, or storage conditions.

For trials conducted in Europe, developing an effective clinical supply plan requires careful evaluation of where to base packaging and distribution operations. Sponsors must consider the advantages and potential limitations of locating these activities within the European Union (EU) or the United Kingdom (UK), particularly in light of evolving regulatory frameworks and cross-border logistics considerations. Each option offers distinct benefits in terms of regulatory access, supply chain flexibility, cost management, and operational efficiency. By assessing these factors early in the planning process, sponsors can make informed decisions that balance cost, flexibility, and scheduling while ensuring reliable supply to clinical sites across the region.